Dr Jonas Völkel advises national and international clients on all matters of intellectual property law.

He advises biotechnology companies on R&D projects, license agreements and questions on trade secret protection. Further, he focuses on the enforcement and defence of claims in intellectual property and unfair competition law.

Jonas studied law in Münster, where he obtained a doctorate in 2021. He worked at the Institute for Information-, Telecommunication- and Media Law (ITM) and in his legal traineeship at the Norwegian Research Center for Computers and Law (NRCCL).

Brightlands Venture Partners and TechVision Fonds

Osborne Clarke has advised Brightlands Venture Partners and TechVision Fonds on their investment in the Organ Vitality Tech start-up Vivalyx GmbH as part of a seed financing round. Read more.

naturalX Health Ventures

Osborne Clarke has advised naturalX Health Ventures, the venture capital arm of Schwabe Group, on its investment in a Series A funding round in nutritional supplement start-up mybacs, read more.

recalm

Osborne Clarke has advised recalm, known for its ANCOR active noise cancelling technology, on its strategic partnership with the agricultural technology and commercial vehicle manufacturer KRONE, read more.

Nosh.bio

Osborne Clarke advises Nosh.bio on seed funding round, read more

Market One Capital and Dutch Founders Fund

Osborne Clarke advises Market One Capital and Dutch Founders Fund on investment in Metycle, read more

Cylib

Osborne Clarke advises battery recycling start-up Cylib on seed funding, read more

Contact Jonas
Share